Table 4. Treatment Characteristics in Relation to Symptomatic Outcome by Sex.

	Sex
Dose and treatment	Men N=1043 (36.3%)		Women N=1833 (63.7%)		Total N=2876		p-value
	n	%	n	%	N	%
Maximum dose of Citalopram (mg/day)							0.0754
< 20	16	1.5	47	2.6	61	2.2
20-39	245	23.6	449	24.5	694	24.2
40-49	299	28.7	563	30.8	862	30.1
≥ 50	480	46.2	770	42.1	1250	43.5
Dose of citalopram at study exit (mg/day)							0.0699
< 20	30	2.9	75	4.1	105	3.7
20-39	273	26.3	511	27.9	784	27.3
40-49	301	28.9	556	30.4	857	29.9
≥ 50	436	41.9	687	37.6	1123	39.1
Time in treatment (weeks)							0.0273
<4	100	9.6	223	12.2	323	11.2
≥4 but <8	145	18.7	290	15.8	485	16.9
≥8	748	71.7	1320	72.0	2068	71.9
	Mean	SD	Mean	SD	Mean	SD
Number of visits	4.8	1.4	4.8	1.6	4.8	1.5	0.8299
Time to first treatment visit (weeks)	2.3	1.1	2.4	1.1	2.3	1.1	0.0485
Time in treatment (weeks)	9.8	3.9	10.2	4.3	10.0	4.2	0.0268
Time from final dose to study exit (weeks)	5.1	4.1	5.1	3.9	5.1	4.0	0.7993